BioCentury
ARTICLE | Clinical News

EndoBarrier Gastrointestinal Liner: Pivotal trial started

January 21, 2013 8:00 AM UTC

GI Dynamics began the double-blind, sham-controlled, U.S. pivotal ENDO trial to evaluate the EndoBarrier Gastrointestinal Liner in about 500 obese Type II diabetics. The product is marketed in Austral...